CIK 0001826457
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Monte Rosa Therapeutics, Inc.
Sign in to watch- Ticker
- GLUE
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-949-2643
- Business address
- 321 HARRISON AVENUE, SUITE 900, BOSTON, MA, 02118
- Former names
- Monte Rosa Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $137
- in 1 filing
Net −$137. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-29 | Manning Anthony M. Director | Exercise or conversion | +10,000 | $4.16 | $42K | 10,000 |
| 2026-06-29 | Manning Anthony M. Director | Sale | −10,000 | $23.11 | $231K | 0 |
| 2026-06-29 | Manning Anthony M. Director | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 2,100 | ||
| 2026-06-11 | Manning Anthony M. Director | Grant or award · Stock Option (Right to Buy) | +25,800 | 25,800 | ||
| 2026-05-21 | Manning Anthony M. Director | Exercise or conversion | +10,000 | $4.16 | $42K | 10,000 |
| 2026-05-21 | Manning Anthony M. Director | Sale | −10,000 | $18.01 | $180K | 0 |
| 2026-05-21 | Manning Anthony M. Director | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 12,100 | ||
| 2025-06-13 | Manning Anthony M. Director | Grant or award · Stock Option (Right to Buy) | +30,700 | 30,700 | ||
| 2024-06-12 | Manning Anthony M. Director | Grant or award · Stock Option (Right to Buy) | +22,100 | 22,100 | ||
| 2023-07-25 | Manning Anthony M. Director | Grant or award · Stock Option (Right to Buy) | +41,000 | 41,000 |
Page 1 of 1 · 10 trades